ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.420
+0.050 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
1.430
+0.010 (0.70%)
After-hours: Dec 5, 2025, 7:49 PM EST
ALX Oncology Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | - | - | 1.18 | |
| Revenue Growth (YoY) | - | - | - | - | - | -75.35% | |
| Cost of Revenue | - | - | - | - | - | 1.08 | |
| Gross Profit | - | - | - | - | - | 0.11 | |
| Selling, General & Admin | 25.56 | 26.09 | 28.48 | 29.04 | 23.39 | 14.81 | |
| Research & Development | 82.88 | 116.37 | 141.8 | 98.4 | 60.17 | 28.96 | |
| Operating Expenses | 108.44 | 142.47 | 170.28 | 127.44 | 83.56 | 43.77 | |
| Operating Income | -108.44 | -142.47 | -170.28 | -127.44 | -83.56 | -43.66 | |
| Interest Expense | -1.65 | -1.73 | -1.57 | -0.24 | -0.01 | - | |
| Interest & Investment Income | 5.27 | 9.37 | 10.65 | 4.28 | 0.09 | 0.12 | |
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | 0.39 | -0.02 | -0.01 | -1.34 | |
| EBT Excluding Unusual Items | -104.84 | -134.85 | -160.81 | -123.42 | -83.48 | -44.88 | |
| Other Unusual Items | - | - | - | - | - | -0.62 | |
| Pretax Income | -108.01 | -134.85 | -160.81 | -123.42 | -83.48 | -45.5 | |
| Income Tax Expense | - | - | - | 0.06 | -0.02 | 0.24 | |
| Net Income | -108.01 | -134.85 | -160.81 | -123.48 | -83.46 | -45.74 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 5.2 | |
| Net Income to Common | -108.01 | -134.85 | -160.81 | -123.48 | -83.46 | -50.94 | |
| Shares Outstanding (Basic) | 54 | 52 | 43 | 41 | 40 | 18 | |
| Shares Outstanding (Diluted) | 54 | 52 | 43 | 41 | 40 | 18 | |
| Shares Change (YoY) | 5.27% | 21.37% | 5.62% | 0.97% | 118.05% | 500.86% | |
| EPS (Basic) | -2.01 | -2.58 | -3.74 | -3.03 | -2.07 | -2.76 | |
| EPS (Diluted) | -2.01 | -2.58 | -3.74 | -3.03 | -2.07 | -2.76 | |
| Free Cash Flow | -97.43 | -122.36 | -131.64 | -90.65 | -68.77 | -38.32 | |
| Free Cash Flow Per Share | -1.82 | -2.35 | -3.06 | -2.23 | -1.71 | -2.07 | |
| Gross Margin | - | - | - | - | - | 9.05% | |
| Operating Margin | - | - | - | - | - | -3693.99% | |
| Profit Margin | - | - | - | - | - | -4309.81% | |
| Free Cash Flow Margin | - | - | - | - | - | -3241.96% | |
| EBITDA | -107.67 | -141.6 | -169.44 | -127.09 | -83.5 | -43.46 | |
| D&A For EBITDA | 0.77 | 0.87 | 0.84 | 0.34 | 0.05 | 0.2 | |
| EBIT | -108.44 | -142.47 | -170.28 | -127.44 | -83.56 | -43.66 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.